CommercialCoverageMedium impact
Genetic Testing for Neurofibromatosis
Blue Cross & Blue Shield of Mississippi·MS · Neurology, Oncology, Pediatrics +3 more·Medical Policy
We identified it
Jun 20, 2026
Summary
BCBS MS has issued a new medical policy A.2.04.137 for genetic testing coverage in neurofibromatosis (NF1, NF2, schwannomatosis). This policy establishes coverage criteria for genetic testing to confirm diagnosis in suspected NF cases that don't meet clinical criteria or to assess risk in asymptomatic relatives.
Action Required
Immediately: Review genetic testing orders for neurofibromatosis patients to ensure they meet the new policy criteria. Billing team should verify that genetic testing requests align with the established indications (confirming diagnosis in suspected NF cases not meeting clinical criteria or determining risk in asymptomatic relatives). Update prior authorization processes to reference policy A.2.04.137 for NF genetic testing claims.